GlassScriptPrepare for your visit
Igor V Shapoval
Family · Clackamas, OR · NPI 1962282749
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$1,469.54
in general payments reported to CMS, 2019-2025 · $1,231 in 2025
The $1,231 reported for 2025 was more than what 90% of Family providers received nationally (typical 2025 total: $167).
Who reported paying
General payments only, top 6 by amount.
- Astrazeneca Pharmaceuticals LP $335.15
- Amgen INC. $257.45
- Aimmune Therapeutics, INC. $249.39
- Salix Pharmaceuticals, A Division of Bausch Health US, LLC $218.02
- Novartis Pharmaceuticals Corporation $140.52
- Axsome Therapeutics, INC. $45.30
Drugs and devices associated with these payments
Xifaxan Airsupra Zenpep Evenity Breztri Leqvio Farxiga Repatha Otezla Auvelity Voquezna Nurtec Odt
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Igor Shapoval listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/11675303/igor-v-shapoval